Girish Mahajan (Editor)

Lexatumumab

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Type  Whole antibody
Target  TRAIL-R2
CAS Number  845816-02-6
Source  Human
ATC code  none
ChemSpider  none

Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.

HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.

References

Lexatumumab Wikipedia


Similar Topics
Buenas noches, Buenos Aires
Curtis Allgier
Phillip Carter (ambassador)
Topics
 
B
i
Link
H2
L